Exelixis, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
EXEL Nasdaq 8731 http://www.exelixis.com 14.89 Stock Up +0.15

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Exelixis, Inc.

6:11 am Exelixis announces its partner Daiichi Sankyo (DSNKY) initiated a phase 3 pivotal trial to evaluate CS-3150 an oral non-steroidal selective mineralocorticoid receptor antagonist as a treatment f - Sep 26th, 2016 10:11 am
4 stocks to watch - Sep 14th, 2016 1:34 pm